The aim of this study was to seek possible links between the regionality along the digestive tract and the accumulation of reactive oxygen species, the effectiveness of the antioxidant defense system and the sensitivity to the types of demise in different gut regions of rats with streptozotocin-induced diabetes. Significant changes were observed in the oxidative status and in the activity of the antioxidant defense system in the diabetic colon; the peroxynitrite production was doubled, the level of hemoxygenase-2 protein was increased 11-fold and the expression of anti-apoptotic bcl-2 was also increased. The segment-specific vulnerability of the gastrointestinal tract induced by hyperglycemia was also confirmed by electron microscopy, demonstrating the presence of severe necrosis in the colon of the diabetic rats. No remarkable histopathological alterations were seen in the duodenum of the diabetic animals and there were likewise no significant changes in the production of peroxynitrite in their duodenum, whereas the level of the free radical scavenger metallothionein-2 was increased ∼300-fold. Conclusion: The spatially restricted vulnerability observed along the digestive tract could originate from a high level of oxidative stress via peroxynitrite production.
Introduction
Type 1 diabetes mellitus (T1D) results in severe metabolic imbalances and pathological changes in many tissues, and commonly affects the entire gastrointestinal (GI) tract, from the esophagus to the anorectal region (Wolosin and Edelman, 2000; Zhao et al., 2002) . T1D involves a state of high oxidative stress generated as a result of hyperglycemia-induced reactive oxygen species (ROS) (Wolff, 1993) . Oxidative stress is an imbalance between the production of ROS, and the ability of a biological system to achieve the ready detoxification of ROS or to repair the resulting damage. While ROS are important second messengers at low concentrations and are involved in the regulation of apoptosis and the activation of transcription factors, they can cause significant cellular damage when present in excess. They can inflict damage on all classes of cellular macromolecular components, eventually leading to tissue injury or even cell death, which can occur essentially by two mechanisms, necrosis and apoptosis (Bergamini et al., 2004) . Although numerous reports have provided details of the molecular mechanisms responsible for ROSinduced apoptosis, little is known concerning the mechanisms and signal transduction pathways underlying ROS-mediated necrotic cell death. Necrosis has long been considered to be a passive mode of cell death (Kanduc et al., 2002) and much more harmful than apoptosis because it causes a robust inflammatory response (Proskuryakov et al., 2003) .
To eliminate the harmful effects of reactive species, cells are equipped with an efficient antioxidant defense system, including enzymes such as superoxide dismutase (SOD), catalase (CAT), and heme oxygenases (HOs), and low-molecular weight antioxidants such as glutathione (GSH) and metallothioneins (MTs) (Kruidenier et al., 2003; Inoue et al., 2008) . SOD catalyzes the reduction of the superoxide anion ( • O 2 − ) to hydrogen peroxide (H 2 O 2 ), which is then detoxified to water by CAT in the lysosomes (Wang and Ballatori, 1998) . The HOs play roles in heme degradation, yielding equimolar amounts of biliverdin, and carbon monoxide with important free radical-scavenging properties and free iron. HO-2 is expressed constitutively, contributing to cell homeostasis, whereas http://dx.doi.org/10.1016/j.biocel.2015.03.005 1357-2725/© 2015 Elsevier Ltd. All rights reserved.
HO-1 is an inducible enzyme expressed at a relatively low level in most tissues (Maines, 1997) , recently identified as an important cellular defense mechanism against oxidative stress (Abraham et al., 2009 ). HO-1 and HO-2 are regulated by strikingly different mechanisms, which may reflect different physiological and pathological roles (Gibbons and Farrugia, 2004) . GSH also plays a critical role in this system, as an antioxidant, enzyme cofactor and major redox buffer (Wang and Ballatori, 1998) . The MTs are present in all cells throughout the body. They have a cardinal role in metal homeostasis and heavy metal detoxification through their high metal-binding capacity, they play a role in the immune function, and they are involved in a variety of GI tract functions (Thirumoorthy et al., 2011) . They also play an important part in the prevention of development of T1D, the complications and the subsequent pathogenic toxicity (Cai, 2004) . The overexpression of MTs in various metabolic organs has been shown to reduce hyperglycemia-induced oxidative stress, organ-specific diabetic complications, and DNA damage in experimental diabetes (Islam and Loots, 2007) .
In an earlier study, we demonstrated spatially-restricted damage of the gut capillary endothelium in rats with streptozotocin (STZ)-induced diabetes in comparison with control animals (Bódi et al., 2012) . Metagenomic analysis of the luminal contents of duodenum, ileum and colon of diabetic rats also furnishes evidence of the regionality of the gut microbiota (Wirth et al., 2014) . The two studies are in good agreement as concerns the advantageous status of the duodenum of the diabetic rat as compared with the colon.
Those results led us to focus in the present study on the spatiallyrestricted differences in ROS production and activation of the antioxidant defense system in the duodenum and colon of rats with STZ-induced diabetes. The aim of the study was to characterize the possible links between the antioxidant status and the macromolecular damage in selected gut segments in the diabetic rat. We report data on the accumulation of a powerful oxidant, peroxynitrite (ONOO − ), the activities of antioxidant enzymes (SOD and CAT), and the expressions of a set of genes coding for members of antioxidant defense system (mt-1, mt-2, ho-1 and ho-2), together with the detection of pro-apoptotic and anti-apoptotic markers (bax, bcl-2 and caspase-9).
Materials and methods

Animal model
Adult male Wistar rats weighing 300-400 g, kept on standard laboratory chow (Bioplan Kft., Hungary) and with free access to drinking water, were used throughout the experiments. The rats were divided randomly into three groups: STZ-induced diabetics (n = 14), insulin-treated diabetics (n = 12) and sex-and age-matched controls (n = 6). Hyperglycemia was induced as described previously (Izbéki et al., 2008) . The animals were considered diabetic if the nonfasting blood glucose concentration was higher than 18 mM. From this time on, one group of hyperglycemic rats received a subcutaneous injection of insulin (Humulin M3, Eli Lilly Nederland) each morning (4 U) and afternoon (2 U). The non-fasting blood glucose concentration and weight of each animal were measured weekly. The cecum size of the sacrificed rat was analyzed by means of the Image J 1.48v program (http://imagej.nih.gov/ij/). In all procedures involving experimental animals, the principles of laboratory animal care (NIH publication no. 85-23, revised 1985) were followed and all the experiments received approval in advance from the Local Ethics Committee for Animal Research Studies at the University of Szeged.
Tissue handling
Ten weeks after the onset of diabetes, the animals were killed by cervical dislocation under chloral hydrate anesthesia (375 mg/kg i.p.). The gut segments of the control, STZ-induced diabetic and insulin-treated diabetic rats were dissected and rinsed in 0.05 M phosphate buffer, pH 7.4. Samples were taken from the duodenum (1 cm distal to the pylorus) and the middle part of the colon and processed for biochemical, molecular biological and electron microscopy study.
2.3. Biochemical assays 0.5 g duodenum and colon of each individual rats, tissues were homogenized in 4 volume of ice-cold 0.9% serum physiologic by means of a glass homogenizer immersed in an ice water bath, centrifuged at 17,000 × g for 15 min at 4 • C, and the clear supernatants used for GSH, ONOO − , protein analysis, and measuring the activities of antioxidant enzymes.
Total protein levels measured by the method of Lowry et al. (1951) using bovine serum albumin as a standard. The concentrations of total and reduced GSH in the tissues were measured as described by Sedlak and Lindsay (1968) . Spectrophotometric measurements were carried out by GENESYS 10S UV-Vis (Thermo Scientific) spectrophotometer.
ONOO − was assayed by diluting samples into 1 M NaOH (60:1) and measuring the increase in absorbance at 302 nm. As a control, samples were added to 100 mM potassium phosphate (pH 7.4) (60:1). The decrease in absorbance was measured at neutral pH as ONOO − decomposes (Huie and Padmaja, 1993) .
Catalase activity was determined spectrophotometrically at 240 nm by the method of Beers and Sizer (1953) and expressed in Bergmeyer units (1 BU = decomposition of 1 g H 2 O 2 /min at 25 • C).
SOD activity was determined on the basis of the inhibition of epinephrine-adrenochrome autoxidation (Misra and Fridovich, 1972) . Spectrophotometric measurement was carried out at 480 nm. The results were expressed in U/mg protein.
Post-embedding immunohistochemistry
For post-embedding immuno-electromicroscopy, small pieces (2-3 mm) of the gut segments were fixed overnight at 4 • C in 2% paraformaldehyde and 2% glutaraldehyde solution, buffered with 0.1 M PB (pH 7.4). The samples were then washed in 0.05 M PB and further fixed for 1 h in 1% OsO 4 . After fixation, the gut segments were rinsed in 0.1 M PB, dehydrated in increasing alcohol concentrations (50, 70, 96% and absolute ethanol) and acetone, and embedded in Epon (Electron Microscopy Sciences, Hatfield, PA, USA). The Epon blocks were used to prepare ultrathin (70 nm) sections, which were mounted on Formvar-coated nickel grids and processed for immunogold labeling.
Ultrathin sections from each block were pre-incubated in 1% bovine serum albumin in TRIS-buffered saline (TBS) for 30 min, incubated overnight in the primary antibodies (heme oxygenase-2 mouse monoclonal IgG (Santa Cruz Biotechnology, USA; working dilution 1:50) and caspase-9 rabbit polyclonal IgG (Sigma-Aldrich, USA; working dilution 1:50)), followed by protein A-gold-conjugated anti-mouse (18 nm gold particles, Jackson ImmunoResearch, West Grove, PA, USA; final dilution 1:20) secondary antibodies for 3 h, with extensive washing in between. All steps were performed at room temperature. The specificity of the immunoreaction was assessed in all cases by omitting the primary antibodies from the labeling protocol and incubating the sections only in the protein A-gold-conjugated secondary antibodies. Sections were counterstained with uranyl acetate (Merck, Darmstadt, Germany) and lead citrate (Merck, Darmstadt, Germany), and were examined and photographed with a Philips CM 10 electron microscope equipped with a MEGAVIEW II camera. The quantitative properties of gold particles coding for HO-2 and caspase-9 were determined in the myenteric ganglia and in the endothelium of capillaries in the vicinity of these ganglia in all experimental group. Counting was performed on digital photographs of five ganglia, and the entire endothelial profile of five well-oriented capillaries, which were cut perpendicularly to their long axis and visualized at a magnification of 5800×, per intestinal segment per condition at a magnification of 34,000× with the AnalySIS 3.2 program (Soft Imaging System GmbH, Münster, Germany). The intensity of the labeling was expressed as the total number of gold particles per unit area.
RNA extraction, reverse transcription and PCR amplification
Intestinal samples were homogenized in RNA Bee reagent (Tel-Test Inc., Friendswood, TX, USA) and total RNA was prepared according to the procedure suggested by the manufacturer. Total RNA was routinely treated with 100 U RNAse-free DNAseI (Thermo Scientific) to avoid any DNA contamination. For assessing RNA concentration and purity the absorbance of a diluted RNA samples were measured at 260 and 280 nm using NanoDrop 1000 UV/VIS Spectrophotometer (Thermo Scientific). The RNA concentration was calculated using the A 260 = 1.0 is equivalent to ∼40 g/ml singlestranded RNA equation. The A 260 /A 280 ratio was used to assess RNA purity and ratio ∼2 was accepted for purified RNA.
First-strand cDNA was synthesized by using 3 g total RNA as template, 200 pmol of each dNTP (Thermo Scientific), 200 U Maxima H Minus Reverse Transcriptase (Thermo Scientific) and 500 pmol random hexamer primers (Sigma) in a final volume of 20 L, and incubated for 10 min at 37 • C, followed by 1 h at 52 • C. Real-time qPCR was done for gene expression studies, using Luminaris Color HiGreen Low ROX qPCR Master Mix (Thermo Scientific) in Applied Biosystems 7500 Real-Time PCR System (Life Technologies). The qPCR reactions were performed with a temperature program of 10 min at 95 • C (initial denaturing), followed by 40 cycles of 15 s at 95 • C; 1 min at the annealing temperature 63 • C followed by a melting curve stage with temperature ramping from 60 to 95 • C and a final cooling for 30 s at 40 • C. The quantities of examined mRNAs were normalized to that of ˇ-actin, a housekeeping gene, and gene expression was calculated in terms of ddCt method (Livak and Schmittgen, 2001) . Table 1 Primer sequences with accession number.
Gene
Primers ( For the amplification of rat mRNAs, isoform-specific primers were designed on the basis of the data bank entries. For normalization of the amounts of mt, ho, caspase-9, bax and bcl-2 mRNAs, the ˇ-actin mRNA level was used as internal standard (Table 1) .
Statistical analysis
RT-qPCR reactions for each animal were performed in triplicate to increase the reliability of the measurements. Statistical analysis was performed with one-way ANOVA and the Newman-Keuls test. All analyses were carried out with GraphPad Prism 4.0 (GraphPad Software, La Jolla, CA, USA) and MedCalc Statistical Software version 9.4.2.0 (MedCalc Software, Mariakerke, Belgium). A probability level of p < 0.05 was set as the level of statistical significance. All data were expressed as means ± SD.
Results
Ischemic and inflammatory hallmarks and peroxynitrite level in different gut segments 10 weeks after the onset of diabetes
Rats were sacrificed and signs of intestinal inflammation and severe ischemia (bluish-purple intestines and an enlarged cecum (1.5-2-fold)) were observed in the diabetic animals as compared with the controls (Fig. 1A and B ). Intestinal ischemia was also visible in the insulin-treated rats, but, the cecum was not enlarged (not shown).
Ten weeks after the onset of diabetes there was no significant change in ONOO − level in the duodenum in any of the examined groups. However, the ONOO − level in the colon was significantly increased (1.7-2-fold) in the diabetic rats, whereas in the insulintreated diabetic animals it was similar to the control level (Fig. 1C) .
Activation of the antioxidant defense system
The GSH level in the duodenum was elevated 2.5-3-fold in the diabetic rats and 1.5-fold in the insulin-treated diabetic rats relative to the control group ( Fig. 2A) . The elevation in the ratio GSH/GSSG was even higher in this intestinal segment: a 6-fold increase was measured in the diabetic animals (data not shown). In the colon, the GSH and GSSG contents were not significantly changed in any of the experimental groups.
The SOD activity was unaltered in the duodenum, regardless of the treatment, while it was significantly decreased in the colon in the diabetic groups (Fig. 2B) . The activity of CAT was not significantly affected by either the STZ-induced diabetes or the insulin replacement in any of the intestinal segments examined (Fig. 2C) .
Ten weeks after the STZ injection, there was a 4-fold increase in the expression of the ho-1 gene in the duodenum, but no significant change in the colon. Immediate insulin replacement maintained the mRNA level close to the control value in both intestinal segments ( Table 2) .
The expression of the mt-1 gene was upregulated in both of the examined gut segments of the diabetic animals: the mt-1 mRNA level was increased by 6-and 7-fold in the duodenum and the colon, respectively. However, no significant change in mt-1 expression was observed in these intestinal segments in the insulin-treated diabetic animals. The mt-2 mRNA content was more than 300-fold the control level in the duodenum of the diabetic animals, while insulin treatment kept the expression level close to the control. The expression of mt-2 did not change in the colon in the diabetic and insulin-treated animals ( Table 2) . 
Table 2
Fold of induction of the ho-1, mt-1 and mt-2 genes in the duodenum and colon of rats with STZ-induced diabetes.
ho-1 mt-1 mt-2 
Measurement of HO-2 expression in different gut segments
The expression of the ho-2 gene was upregulated significantly only in the colon in the diabetic and the insulin-treated diabetic rats (Fig. 3A) . The presence of HO-2 protein was followed by post-embedding immunohistochemistry. A ∼4-fold increase was measured in the number of gold particles signing HO-2 in the duodenum of the diabetic animals relative to the controls. In the diabetic colon, there was a marked 11-fold elevation in the HO-2 labels resulting in a ∼5-fold higher protein level of HO-2 in the colon versus duodenum. In both examined regions of the insulin-treated diabetic rats the control level of HO-2 expression was observed (Fig. 3B) .
Effects of diabetes on apoptotic markers in the duodenum and colon
We examined the levels of the pro-apoptotic marker bax and the anti-apoptotic marker bcl-2. In the duodenum of the diabetic rat, a 40% increase was detected in the level of bax mRNA as compared with the control and insulin-treated groups. However, in the colon of the diabetic rats, the expression of the bax gene was downregulated by 15-20% (data not shown). The diabetes-induced alterations in the expression of the anti-apoptotic marker blc-2 were the opposite of those in bax expression; no change or a non-significant decrease in the duodenum, and a 40-45% increase in the colon. As a consequence, the ratio bax/bcl-2 differed even more dramatically in the two intestinal segments: a 50% increase in the duodenum, and a 40% decrease in the colon (Fig. 4A) .
The expression pattern of caspase-9 in the duodenum was similar to that of bax. There was a significant 2.5-3-fold increase in the caspase-9 mRNA level in the diabetic rats. The expression pattern of this gene was unchanged in the colon in the diabetic animals and the level was the same as the control in the animals treated with insulin (Fig. 4B) . The intestinal caspase-9 protein expression was also demonstrated by immunohistochemistry. The number of gold particles labeling caspase-9 was significantly higher in the duodenum of diabetic rats than the control (Fig. 4C and D) , while the number of labels in the colon was unchanged.
The segment-specific vulnerability of the gastrointestinal tract induced by hyperglycemia was also confirmed by electron microscopy, demonstrating the presence of severe necrosis in the colon of the diabetic rats. The hyperglycemic colon samples frequently exhibited necrotic smooth muscle cells with a barely recognizable cytoplasm, and the structural integrity of the plasma membrane was lost (Fig. 5) .
Discussion
This study has presented data on gut segment specific oxidative stress, the effectiveness of the antioxidant defense system and the tissue damage in the duodenum and colon in rats with diabetes.
The segment-specific vulnerability of the GI tract was confirmed by RT-qPCR, immunohistochemistry and electron microscopy (EM). EM demonstrated the presence of severe necrosis in the colon of the diabetic rats. Changes in ROS production, as presumptive candidates triggering necrosis were also demonstrated in the colon: the ONOO − production was doubled. Elevated level of ONOO − serves as indirect evidence of increased • O 2 − and NO production in the colon. An increasing number of studies have implicated ONOO − in the development of T1D-associated complications (Pacher et al., 2007) . A study of the pathogenesis of inflammatory bowel disease yielded evidence that intrarectally administered ONOO − induced inflammation and transmucosal necrosis in the rat colon (Rachmilewitz et al., 1993) . The activity of SOD in the diabetic colon was significantly reduced, which status also could be a consequence of the fast depletion of • O 2 − through its reaction with NO, which is 3 times faster than the SOD-catalyzed reduction of • O 2 − (Walsh, 1997) .
Or study has also demonstrated that the intestine possesses several defense mechanisms in a segment-specific manner: maintains high concentrations of the antioxidant GSH and upregulates the expressions of hos and mts so as to preserve cellular integrity.
GSH is present in high concentrations in the tissues and participates in the cellular defense by scavenging ROS (Nicotera and Orrenius, 1986; Flechner et al., 1990) . Our study has revealed a marked increase in GSH level in the duodenal tissues, but not in the colon, in diabetic rats. High GSH levels protect cellular proteins against oxidation through the GSH redox cycle, and also directly detoxify ROS induced by exposure to STZ (Raza et al., 2000) . Besides the GSH system, the MTs also play a noteworthy role in the maintenance of the physiological thiol/redox balance. The MTs may serve as potent antioxidants preventing diabetic complications through the suppression of diabetic oxidative damage (Dabrowiak, 2009) . Our study revealed the accumulation of a huge amount of mt-2 mRNA in the diabetic duodenum. The expression of mt-1 was induced to about the same level in the diabetic duodenum and colon. In the colon, this 7-fold elevation in mt-1 mRNA level is one of the few positive signs of an active antioxidant defense. It has been documented that Zn-induced mt synthesis in rat pancreas prevented STZ-induced diabetes (Yang and Cherian, 1994) . Elevated levels of MTs in the liver and kidney of diabetic rats have also been reported (Craft and Failla, 1983; Failla and Kiser, 1981; Uriu Hare et al., 1988) , and overexpressed mt in the mouse heart significantly prevented diabetes-induced cardiomyopathy Kang and Cai, 2001) .
We also demonstrated gut segment-specific changes in the expression of the HOs during diabetes. A number of in vivo and in vitro studies have indicated the induction of the HO system in response to a wide array of oxidative and cellular stresses (Applegate et al., 1991; Nath, 1994; Vile et al., 1994; Otterbein et al., 1995) . HO-1 and HO-2 share similar physical and kinetic properties, but have different physiological roles and tissue distributions (Maines, 2005 ). In our system, hyperglycemia induced ho-1 expression in the duodenum, while in the colon increased amounts of ho-2 mRNA and HO-2 protein were detected. Unlike HO-1, which lacks Fig. 4 . Expressions of apoptotic markers in the duodenum and colon. Ratio bax/bcl-2 (A) and expression of caspase-9 gene (B) in different gut segments of control (C) n = 6, diabetic (D) n = 14 and insulin-treated diabetic (ID) n = 12 rats. Data are expressed as fold of induction. Representative electron micrograph of ultrathin section of the enteric smooth muscle cells (smc) in the duodenum of diabetic rat after post-embedding immunohistochemistry (C), using a caspase-9-specific primary antibody. The majority of the 18 nm gold particles (arrows) labeling caspase-9 accumulated above the mitochondria (m). Bar: 500 nm. Quantitative evaluation of the number of gold particles labeling caspase-9 (D). All values are presented as means ± S.D. *p < 0.05, **p < 0.01, ***p < 0.001 (relative to controls). cysteine residues, HO-2 contains three Cys-Pro signature motifs, known as heme regulatory motifs (HRMs). It has been proposed (Ragsdale and Yi, 2011 ) that the HRMs act as a "molecular rheostat" that responds to the intracellular redox potential, controlling the HO-2 activity. The level of HO-2 protein increased 11-fold, and the activity could be further enhanced by free radicals via the Cys-Pro signature motifs. The release of Fe ion during heme degradation before their sequestration by ferritin may make them available for the catalysis of harmful oxidation reactions (Rouault, 2009 ).
HO overexpression results in an anti-apoptotic phenotype associated with an increased expression of bcl-2 in diabetic rats (Cao et al., 2008) . The survival function of bcl-2 depends on the extent of binding to proteins such as Bax that seem to antagonize bcl-2 activity (Ashkenazi and Dixit, 1998; Kroemer, 1997) . Our study has presented evidence of the gut region-specific expression of bcl-2, bax and caspase-9 the key elements of apoptotic pathways (Thornberry and Lazebnik, 1998) . In the duodenal tissues of the diabetic rats, the level of bax expression was increased, resulting in major changes in the ratio bax/bcl-2 mRNA. These changes, along with an increased level of caspase-9, an initiator caspase in the apoptosis pathway, indicate an enhanced pro-apoptotic environment, triggering the event of programmed cell death in the duodenum. In the diabetic colon the ratio bax/bcl-2 is lowered as a consequence of upregulation of the bcl-2 expression. The observed increase in bcl-2 expression could possibly be attributed to the highly elevated HO-2 level.
All of these data suggest that the colon is more vulnerable than the duodenum to oxidative stress. The fact that the antioxidant protection is more efficient in the proximal intestinal sections than in the distal sections may be a consequence of the positional and functional differences (Blázovics et al., 2004) . Earlier findings supported this (Sanders et al., 2004) : the colon generates more endogenous ROS than does the small intestine, and this basic pro-oxidant environment of the colon may lead to its inability to handle oxidative stress as effectively as the small intestine. A recent study on intestinal bacterial populations in T1D likewise emphasized regionality along the GI tract; T1D affected the composition of the microbiota in a gut region-specific manner: the composition of the duodenal microbiota did not indicate the development of a pathological enteric microenvironment. In the diabetic colon however, the increased level of the Gram-negative Klebsiella could be associated with severe intestinal inflammation (Wirth et al., 2014) .
